0001203311-14-000020.txt : 20140224
0001203311-14-000020.hdr.sgml : 20140224
20140224192554
ACCESSION NUMBER: 0001203311-14-000020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140220
FILED AS OF DATE: 20140224
DATE AS OF CHANGE: 20140224
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DRACHMAN JONATHAN G
CENTRAL INDEX KEY: 0001588467
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 14638447
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2014-02-20
0
0001060736
SEATTLE GENETICS INC /WA
SGEN
0001588467
DRACHMAN JONATHAN G
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
CMO & EVP, R & D
Common Stock
2014-02-20
4
S
0
1241.0
53.25
D
48670
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Drachman on September 16, 2013.
Amount of securities beneficially owned following reported transactions includes 48,500 Restricted Stock Units subject to vesting.
Jonathan G. Drachman
2014-02-24